SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-407640

SYN-068

[SYN] Uniform Hydra · 71y · Male · Chinese · BMI 24.6 · ECOG 1
SMCAS - Sunway Medical Centre AS · Medical Oncology · Dr. Chong Boon Keat
IIIA (T4, N0)Stable
EGFR Exon 20 InsTP53
Clinical storyline

[SYN] Uniform Hydra, a 71-year-old Chinese male (never, ECOG 1), presented in 2025-09 with fatigue and reduced appetite. Workup confirmed Adenocarcinoma (Stage III, EGFR Exon 20 Ins). The MDT recommended first-line osimertinib. Current status: Stable.

HPE Results
Poorly differentiated NSCLC adenocarcinoma, EGFR Exon 20 insertion
Clinical Stage
IIIA (T4, N0)
Pathological Stage
IIIA (T4, N0, Mx)
Adenocarcinoma Subtype
Poorly differentiated adenocarcinoma
CEA (ng/mL)
30.1
Tumor (CT/PET)
3.4 cm
PET SUV
14.01
NGS Results
1. EGFR Exon 20 Insertion
2. TP53 H193R